Screener
AngioDynamics ANGO CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Accounts payable, accrued and other liabilities | (5,833) | (15,877) | 27,531 |
| Net cash provided by (used in) operating activities | 3,089 | (10,128) | (28,158) |
| Cash flows from investing activities: | |||
| Additions to property, plant and equipment | (2,581) | (4,464) | (2,518) |
| Additions to placement and evaluation units | (3,368) | (5,714) | (5,015) |
| Proceeds from sale of assets | — | — | 134,500 |
| Acquisition of intangibles | — | — | (3,250) |
| Net cash (used in) provided by investing activities | (5,949) | (10,178) | 123,717 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's capex?
- AngioDynamics (ANGO) reported capex of $413K in Q1 2026.
- How has AngioDynamics's capex changed year-over-year?
- AngioDynamics's capex decreased by 46.8% year-over-year, from $777K to $413K.
- What is the long-term trend for AngioDynamics's capex?
- Over 4 years (2022 to 2026), AngioDynamics's capex has grown at a -12.0% compound annual growth rate (CAGR), from $4.3M to $2.58M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about AngioDynamics's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude